Vyome Holdings/$HIND
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vyome Holdings
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Ticker
$HIND
Sector
Primary listing
Employees
14
Headquarters
Website
Vyome Holdings Metrics
BasicAdvanced
$15m
-
-$2.85
-
-
Price and volume
Market cap
$15m
52-week high
$12.87
52-week low
$1.75
Average daily volume
32k
Financial strength
Current ratio
4.273
Quick ratio
4.168
Total debt to equity
0.28
Interest coverage (TTM)
-38.91%
Profitability
EBITDA (TTM)
-3.667
Gross margin (TTM)
53.03%
Net profit margin (TTM)
-7,157.32%
Operating margin (TTM)
-2,408.64%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-39.54%
Return on equity (TTM)
-665.57%
Valuation
Price to revenue (TTM)
54.724
Price to book
2.27
Price to tangible book (TTM)
2.38
Price to free cash flow (TTM)
-1.678
Free cash flow yield (TTM)
-59.60%
Free cash flow per share (TTM)
-1.299
Growth
Revenue change (TTM)
-59.66%
Vyome Holdings News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs